Related Experiment Videos
Single injection treatment of meningococcal meningitis. 1. Long-acting penicillin
Abstract:
A single injection of a long-acting preparation of penicillin (Triplopen) was compared with a five-day course of crystalline and procaine penicillin in the treatment of meningococcal meningitis. The clinical response of patients treated with Triplopen was very similar to that of patients treated with crystalline penicillin and much more convenient to administer. However, four patients treated with Triplopen had a positive CSF culture 48 or 72 hours after their injection. One injection of Triplopen cannot, therefore, be recommended as an entirely safe form of treatment for meningococcal meningitis unless patients can be carefully followed.
Insights
A single Triplopen injection for meningococcal meningitis showed similar clinical results to standard penicillin but had a risk of positive CSF cultures. Careful patient monitoring is essential if using this convenient, long-acting penicillin preparation.
Area of Science:
- Infectious Diseases
- Microbiology
- Pharmacology
Background:
- Meningococcal meningitis remains a significant public health concern.
- Effective antibiotic treatment is crucial for patient outcomes.
- Long-acting antibiotic formulations offer potential convenience in treatment administration.
Purpose of the Study:
- To compare the efficacy and safety of a single injection of long-acting penicillin (Triplopen) versus a five-day course of standard penicillin regimens for treating meningococcal meningitis.
- To evaluate the clinical response and microbiological clearance in patients receiving Triplopen.
Main Methods:
- A comparative study involving patients diagnosed with meningococcal meningitis.
- Treatment groups included a single injection of Triplopen and a five-day course of crystalline and procaine penicillin.
- Cerebrospinal fluid (CSF) cultures were monitored at 48 and 72 hours post-treatment.
Main Results:
- Clinical responses were similar between the Triplopen group and the crystalline penicillin group.
- Triplopen offered greater convenience in administration compared to multi-day regimens.
- Four patients in the Triplopen group had positive CSF cultures 48 or 72 hours post-injection, indicating potential treatment failure or persistent infection.
Conclusions:
- While Triplopen provides a convenient alternative for meningococcal meningitis treatment, its safety is questionable due to positive CSF cultures in some patients.
- A single injection of Triplopen is not recommended as a standalone treatment without rigorous patient follow-up.
- Further investigation into the optimal use and monitoring of long-acting penicillin in meningitis is warranted.